Global Sexual Dysfunction Drugs Market Report, History and Forecast 2013-2025, Breakdown Data by Companies, Key Regions, Types and Application

This report studies the Sexual Dysfunction Drugs market size by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in the market.

The sexual dysfunction oral drugs segment accounted for the majority market share during 2017 and will continue to grow during the forecast period. The increasing cases of sexual dysfunctions are driving the need for oral therapies such as 5HT1A receptor agonist. The demand for sexual dysfunction oral drugs such as ED drugs will further increase due to the rising awareness among healthcare professionals.

The demand for sexual dysfunction drugs is increasing due to the rising prevalence of chronic diseases such as prostate cancer, diabetes mellitus, and CVD. The market will continue to grow in the region in the forthcoming years due to the rise in unhealthy lifestyle habits and the increased risk of developing sexual dysfunctions among the population.

In 2017, the global Sexual Dysfunction Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% between 2018 and 2025.

This report focuses on the global top players, covered

Pfizer

GlaxoSmithKline

Merck

Eli Lilly

AbbVie

Bayer

Teva Pharmaceutical Industries

Takeda

Apricus Biosciences

Emotional Brain

Ivix LLX

Leadiant Biosciences

NexMed

S1 Biopharma

Vietstar Biomedical Research

Market segment by Regions/Countries, this report covers

North America

Europe

China

Rest of Asia Pacific

Central & South America

Middle East & Africa

Market segment by Type, the product can be split into

Oral Therapy

Intracavernosal Therapy

Hormonal Therapy

Transurethral Therapy

Market segment by Application, the market can be split into

Male

Female

The study objectives of this report are:

To study and forecast the market size of Sexual Dysfunction Drugs in global market.

To analyze the global key players, SWOT analysis, value and global market share for top players.

To define, describe and forecast the market by type, end use and region.

To analyze and compare the market status and forecast among global major regions.

To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Sexual Dysfunction Drugs are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Raw material suppliers

Distributors/traders/wholesalers/suppliers

Regulatory bodies, including government agencies and NGO

Commercial research & development (R&D) institutions

Importers and exporters

Government organizations, research organizations, and consulting firms

Trade associations and industry bodies

End-use industries

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Further breakdown of Sexual Dysfunction Drugs market on basis of the key contributing countries.

Detailed analysis and profiling of additional market players.

Research Methodology:-

Medical care is the effective as well as the guided design of all types of medical services to the people. Medical care generally revolves around service design such as patient’s safety, integrated care and patient-centered care. The topic of medical care also explores innovative and latest ideas on exactly how to develop a team of physicians in areas where medical leadership and qualitative improvement have been given utmost importance. Considering the significance of the medical care industry across the globe, QY Research has delivered impartial, insightful and complete research report which offers a crystal clear picture of prominent as well as niche markets in the industry.  

In an attempt to make this report an exclusive one, the expert team of analysts covered the various markets under the medical care industry in detail. Further, they have explored several market dynamics such as trends, opportunities, drivers and restraints to give a transparent view of this highly competitive industry. To arrive at market numbers, QY Research’s analysts have evaluated the available data over different parameters. Apart from this, one of the important section which is known as the competitive landscape has also been covered in the report. This section has given information about the top players functioning in the medical care industry. 

Medical care industry witnesses major growth in the United States since past few years

The significant regions such as Latin America, North America, Western and Eastern Europe, Middle East and Africa and the Asia Pacific including Japan are included in this report. Apart from this broad category of regions some of the niche countries, particularly in the Asia Pacific such as Malaysia, Indonesia, and Vietnam and in Latin America such as Mexico are evaluated in this report. The US lens on worldwide trends and opportunities for health systems and plans. De-hospitalization and self-aggregation are two prominent forces which are expected to drive the medical industry in the US. In the Asia Pacific region, the medical industry is expected to boom in China and India in the years to come. Increasing population, rising disposable income, and a growing geriatric population are some of the factors, which are responsible for the growth of the medical care industry in the Asia Pacific region.

A lucid analysis of competitive landscape in the medical industry makes QY Research’s report a unique one

As mentioned above, the competitive landscape section is the most significant section in this report and that is the reason the research analysts in QY Research has left no stone unturned while examining the various markets in the medical care industry. This section offers comprehensive information about the product overview, the overview of the company, and key financial and key developments related to that specific company.

Other prominent features of this section include SWOT analysis of selected companies. SWOT analysis helps in providing information about weaknesses and strength, threats and opportunities that are faced by the companies functioning in the medical care industry. Competitive landscape indeed an invaluable part of this report as it includes all the required information to study the key players operating in the medical care industry. A detailed analysis of leading companies’ strategies and their vision to sustain in this highly competitive industry is one of the significant features of this report. 

Segmental Analysis

The markets covered under the purview of the medical care industry are generally segmented as, by product, by application, by an end user and by region. QY Research has given emphasis on providing segmental analysis in a comprehensive way for the better understanding of the overall market. To effectively gather market values, weighted average selling prices have been taken into consideration on the basis of products.

Further, to make this report detail and wide-ranging QY Research has used a top-down approach to evaluate market numbers for almost every category of products. On the other hand, to counter validate all the market estimations, the bottom-up approach has been used by the experts in the medical care industry. While examining different segments of the markets in the medical care industry, the analysts in QY Research have carried out several surveys along with detailed primary research.

Key takeaways from this report

Stakeholders in the medical care industry are following new measures of cost reduction, for example, developing the models of alternative staffing, reduction in supply and administrative cost and shifting patients to outpatient services. Additionally, the key players in the market are also discovering new sources of revenue such as launching new companies, capitalization of intellectual property and commercializing their foreign assets.

QY Research founded in 2007, focuses on IPO and management consulting, chain research of various industries and seminar services and database. The company has its own primary databases such as Industry Association Database, customs export and import database, database of national bureau of statistics and resource from industry experts who have more than ten years’ experience of associating with Research & development industries of consumer goods, energy, Internet and Communication, automotive, medical, and chemicals. QY Research has so far served many Fortune 500 companies. 

Table of Contents

Sexual Dysfunction Drugs Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025

1 Industry Overview of Sexual Dysfunction Drugs

1.1 Sexual Dysfunction Drugs Market Overview

1.1.1 Sexual Dysfunction Drugs Product Scope

1.1.2 Market Status and Outlook

1.2 Global Sexual Dysfunction Drugs Market Size and Analysis by Regions

1.2.1 North America

1.2.2 Europe

1.2.3 China

1.2.4 Rest of Asia Pacific

1.2.5 Central & South America

1.2.6 Middle East & Africa

1.3 Sexual Dysfunction Drugs Market by Type

1.3.1 Oral Therapy

1.3.2 Intracavernosal Therapy

1.3.3 Hormonal Therapy

1.3.4 Transurethral Therapy

1.4 Sexual Dysfunction Drugs Market by End Users/Application

1.4.1 Male

1.4.2 Female

2 Global Sexual Dysfunction Drugs Competition Analysis by Players

2.1 Sexual Dysfunction Drugs Market Size (Value) by Players (2017 and 2018)

2.2 Competitive Status and Trend

2.2.1 Market Concentration Rate

2.2.2 Product/Service Differences

2.2.3 New Entrants

2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles

3.1 Pfizer

3.1.1 Company Profile

3.1.2 Main Business/Business Overview

3.1.3 Products, Services and Solutions

3.1.4 Sexual Dysfunction Drugs Revenue (Value) (2013-2018)

3.1.5 Recent Developments

3.2 GlaxoSmithKline

3.2.1 Company Profile

3.2.2 Main Business/Business Overview

3.2.3 Products, Services and Solutions

3.2.4 Sexual Dysfunction Drugs Revenue (Value) (2013-2018)

3.2.5 Recent Developments

3.3 Merck

3.3.1 Company Profile

3.3.2 Main Business/Business Overview

3.3.3 Products, Services and Solutions

3.3.4 Sexual Dysfunction Drugs Revenue (Value) (2013-2018)

3.3.5 Recent Developments

3.4 Eli Lilly

3.4.1 Company Profile

3.4.2 Main Business/Business Overview

3.4.3 Products, Services and Solutions

3.4.4 Sexual Dysfunction Drugs Revenue (Value) (2013-2018)

3.4.5 Recent Developments

3.5 AbbVie

3.5.1 Company Profile

3.5.2 Main Business/Business Overview

3.5.3 Products, Services and Solutions

3.5.4 Sexual Dysfunction Drugs Revenue (Value) (2013-2018)

3.5.5 Recent Developments

3.6 Bayer

3.6.1 Company Profile

3.6.2 Main Business/Business Overview

3.6.3 Products, Services and Solutions

3.6.4 Sexual Dysfunction Drugs Revenue (Value) (2013-2018)

3.6.5 Recent Developments

3.7 Teva Pharmaceutical Industries

3.7.1 Company Profile

3.7.2 Main Business/Business Overview

3.7.3 Products, Services and Solutions

3.7.4 Sexual Dysfunction Drugs Revenue (Value) (2013-2018)

3.7.5 Recent Developments

3.8 Takeda

3.8.1 Company Profile

3.8.2 Main Business/Business Overview

3.8.3 Products, Services and Solutions

3.8.4 Sexual Dysfunction Drugs Revenue (Value) (2013-2018)

3.8.5 Recent Developments

3.9 Apricus Biosciences

3.9.1 Company Profile

3.9.2 Main Business/Business Overview

3.9.3 Products, Services and Solutions

3.9.4 Sexual Dysfunction Drugs Revenue (Value) (2013-2018)

3.9.5 Recent Developments

3.10 Emotional Brain

3.10.1 Company Profile

3.10.2 Main Business/Business Overview

3.10.3 Products, Services and Solutions

3.10.4 Sexual Dysfunction Drugs Revenue (Value) (2013-2018)

3.10.5 Recent Developments

3.11 Ivix LLX

3.12 Leadiant Biosciences

3.13 NexMed

3.14 S1 Biopharma

3.15 Vietstar Biomedical Research

4 Global Sexual Dysfunction Drugs Market Size by Type and Application (2013-2018)

4.1 Global Sexual Dysfunction Drugs Market Size by Type (2013-2018)

4.2 Global Sexual Dysfunction Drugs Market Size by Application (2013-2018)

4.3 Potential Application of Sexual Dysfunction Drugs in Future

4.4 Top Consumer/End Users of Sexual Dysfunction Drugs

5 North America Sexual Dysfunction Drugs Development Status and Outlook

5.1 North America Sexual Dysfunction Drugs Market Size (2013-2018)

5.2 North America Sexual Dysfunction Drugs Market Size and Market Share by Players (2017 and 2018)

6 Europe Sexual Dysfunction Drugs Development Status and Outlook

6.1 Europe Sexual Dysfunction Drugs Market Size (2013-2018)

6.2 Europe Sexual Dysfunction Drugs Market Size and Market Share by Players (2017 and 2018)

7 China Sexual Dysfunction Drugs Development Status and Outlook

7.1 China Sexual Dysfunction Drugs Market Size (2013-2018)

7.2 China Sexual Dysfunction Drugs Market Size and Market Share by Players (2017 and 2018)

8 Rest of Asia Pacific Sexual Dysfunction Drugs Development Status and Outlook

8.1 Rest of Asia Pacific Sexual Dysfunction Drugs Market Size (2013-2018)

8.2 Rest of Asia Pacific Sexual Dysfunction Drugs Market Size and Market Share by Players (2017 and 2018)

9 Central & South America Sexual Dysfunction Drugs Development Status and Outlook

9.1 Central & South America Sexual Dysfunction Drugs Market Size (2013-2018)

9.2 Central & South America Sexual Dysfunction Drugs Market Size and Market Share by Players (2017 and 2018)

10 Middle East & Africa Sexual Dysfunction Drugs Development Status and Outlook

10.1 Middle East & Africa Sexual Dysfunction Drugs Market Size (2013-2018)

10.2 Middle East & Africa Sexual Dysfunction Drugs Market Size and Market Share by Players (2017 and 2018)

11 Market Forecast by Regions, Type and Application (2018-2025)

11.1 Global Sexual Dysfunction Drugs Market Size (Value) by Regions (2018-2025)

11.1.1 North America Sexual Dysfunction Drugs Revenue and Growth Rate (2018-2025)

11.1.2 Europe Sexual Dysfunction Drugs Revenue and Growth Rate (2018-2025)

11.1.3 China Sexual Dysfunction Drugs Revenue and Growth Rate (2018-2025)

11.1.4 Rest of Asia Pacific Sexual Dysfunction Drugs Revenue and Growth Rate (2018-2025)

11.1.5 Central & South America Sexual Dysfunction Drugs Revenue and Growth Rate (2018-2025)

11.1.6 Middle East & Africa Sexual Dysfunction Drugs Revenue and Growth Rate (2018-2025)

11.2 Global Sexual Dysfunction Drugs Market Size (Value) by Type (2018-2025)

11.3 Global Sexual Dysfunction Drugs Market Size by Application (2018-2025)

12 Sexual Dysfunction Drugs Market Dynamics

12.1 Sexual Dysfunction Drugs Market Opportunities

12.2 Sexual Dysfunction Drugs Challenge and Risk

12.2.1 Competition from Opponents

12.2.2 Downside Risks of Economy

12.3 Sexual Dysfunction Drugs Market Constraints and Threat

12.3.1 Threat from Substitute

12.3.2 Government Policy

12.3.3 Technology Risks

12.4 Sexual Dysfunction Drugs Market Driving Force

12.4.1 Growing Demand from Emerging Markets

12.4.2 Potential Application

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs Trend/Customer Preference

13.3 External Environmental Change

13.3.1 Economic Fluctuations

13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Sexual Dysfunction Drugs Product Scope

Figure Global Sexual Dysfunction Drugs Market Size (Million USD) (2013-2018)

Table Global Sexual Dysfunction Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Figure Global Sexual Dysfunction Drugs Market Share by Regions in 2017

Figure North America Sexual Dysfunction Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Figure Europe Sexual Dysfunction Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Figure China Sexual Dysfunction Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Figure Rest of Asia Pacific Sexual Dysfunction Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Figure Central & South America Sexual Dysfunction Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Figure Middle East & Africa Sexual Dysfunction Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Figure Global Sexual Dysfunction Drugs Market Share by Type in 2017

Figure Oral Therapy Market Size (Million USD) and Growth Rate (2013-2018)

Figure Intracavernosal Therapy Market Size (Million USD) and Growth Rate (2013-2018)

Figure Hormonal Therapy Market Size (Million USD) and Growth Rate (2013-2018)

Figure Transurethral Therapy Market Size (Million USD) and Growth Rate (2013-2018)

Figure Global Sexual Dysfunction Drugs Market Share by Application in 2017

Table Key Downstream Customer in Male

Figure Sexual Dysfunction Drugs Market Size (Million USD) and Growth Rate in Male (2013-2018)

Table Key Downstream Customer in Female

Figure Sexual Dysfunction Drugs Market Size (Million USD) and Growth Rate in Female (2013-2018)

Table Sexual Dysfunction Drugs Market Size (Million USD) by Players (2017 and 2018)

Figure Sexual Dysfunction Drugs Market Size Share by Players in 2017

Figure Sexual Dysfunction Drugs Market Size Share by Players in 2018

Table Pfizer Basic Information List

Table Sexual Dysfunction Drugs Business Revenue (Million USD) of Pfizer (2013-2018)

Figure Pfizer Sexual Dysfunction Drugs Business Revenue Market Share in 2017

Table GlaxoSmithKline Basic Information List

Table Sexual Dysfunction Drugs Business Revenue (Million USD) of GlaxoSmithKline (2013-2018)

Figure GlaxoSmithKline Sexual Dysfunction Drugs Business Revenue Market Share in 2017

Table Merck Basic Information List

Table Sexual Dysfunction Drugs Business Revenue (Million USD) of Merck (2013-2018)

Figure Merck Sexual Dysfunction Drugs Business Revenue Market Share in 2017

Table Eli Lilly Basic Information List

Table Sexual Dysfunction Drugs Business Revenue (Million USD) of Eli Lilly (2013-2018)

Figure Eli Lilly Sexual Dysfunction Drugs Business Revenue Market Share in 2017

Table AbbVie Basic Information List

Table Sexual Dysfunction Drugs Business Revenue (Million USD) of AbbVie (2013-2018)

Figure AbbVie Sexual Dysfunction Drugs Business Revenue Market Share in 2017

Table Bayer Basic Information List

Table Sexual Dysfunction Drugs Business Revenue (Million USD) of Bayer (2013-2018)

Figure Bayer Sexual Dysfunction Drugs Business Revenue Market Share in 2017

Table Teva Pharmaceutical Industries Basic Information List

Table Sexual Dysfunction Drugs Business Revenue (Million USD) of Teva Pharmaceutical Industries (2013-2018)

Figure Teva Pharmaceutical Industries Sexual Dysfunction Drugs Business Revenue Market Share in 2017

Table Takeda Basic Information List

Table Sexual Dysfunction Drugs Business Revenue (Million USD) of Takeda (2013-2018)

Figure Takeda Sexual Dysfunction Drugs Business Revenue Market Share in 2017

Table Apricus Biosciences Basic Information List

Table Sexual Dysfunction Drugs Business Revenue (Million USD) of Apricus Biosciences (2013-2018)

Figure Apricus Biosciences Sexual Dysfunction Drugs Business Revenue Market Share in 2017

Table Emotional Brain Basic Information List

Table Sexual Dysfunction Drugs Business Revenue (Million USD) of Emotional Brain (2013-2018)

Figure Emotional Brain Sexual Dysfunction Drugs Business Revenue Market Share in 2017

Table Ivix LLX Basic Information List

Table Leadiant Biosciences Basic Information List

Table NexMed Basic Information List

Table S1 Biopharma Basic Information List

Table Vietstar Biomedical Research Basic Information List

Table Global Sexual Dysfunction Drugs Market Size (Million USD) by Type (2013-2018)

Figure Global Sexual Dysfunction Drugs Market Size Share by Type in 2013

Figure Global Sexual Dysfunction Drugs Market Size Share by Type in 2014

Figure Global Sexual Dysfunction Drugs Market Size Share by Type in 2015

Figure Global Sexual Dysfunction Drugs Market Size Share by Type in 2016

Figure Global Sexual Dysfunction Drugs Market Size Share by Type in 2017

Figure Global Sexual Dysfunction Drugs Market Size Share by Type in 2018

Table Global Sexual Dysfunction Drugs Market Size (Million USD) by Application (2013-2018)

Figure Global Sexual Dysfunction Drugs Market Size (Million USD) by Application in 2013

Figure Global Sexual Dysfunction Drugs Market Size (Million USD) by Application in 2014

Figure Global Sexual Dysfunction Drugs Market Size (Million USD) by Application in 2015

Figure Global Sexual Dysfunction Drugs Market Size (Million USD) by Application in 2016

Figure Global Sexual Dysfunction Drugs Market Size (Million USD) by Application in 2017

Figure Global Sexual Dysfunction Drugs Market Size (Million USD) by Application in 2018

Table Top Consumer/End Users of Sexual Dysfunction Drugs

Figure North America Sexual Dysfunction Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Table North America Sexual Dysfunction Drugs Market Size (Million USD) by Players (2013-2018)

Figure North America Sexual Dysfunction Drugs Market Size Share by Players in 2017

Figure North America Sexual Dysfunction Drugs Market Size Share by Players in 2018

Figure Europe Sexual Dysfunction Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Table Europe Sexual Dysfunction Drugs Market Size (Million USD) by Players (2013-2018)

Figure Europe Sexual Dysfunction Drugs Market Size Share by Players in 2017

Figure Europe Sexual Dysfunction Drugs Market Size Share by Players in 2018

Figure China Sexual Dysfunction Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Table China Sexual Dysfunction Drugs Market Size (Million USD) by Players (2013-2018)

Figure China Sexual Dysfunction Drugs Market Size Share by Players in 2017

Figure China Sexual Dysfunction Drugs Market Size Share by Players in 2018

Figure Rest of Asia Pacific Sexual Dysfunction Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Table Rest of Asia Pacific Sexual Dysfunction Drugs Market Size (Million USD) by Players (2013-2018)

Figure Rest of Asia Pacific Sexual Dysfunction Drugs Market Size Share by Players in 2017

Figure Rest of Asia Pacific Sexual Dysfunction Drugs Market Size Share by Players in 2018

Figure Central & South America Sexual Dysfunction Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Table Central & South America Sexual Dysfunction Drugs Market Size (Million USD) by Players (2013-2018)

Figure Central & South America Sexual Dysfunction Drugs Market Size Share by Players in 2017

Figure Central & South America Sexual Dysfunction Drugs Market Size Share by Players in 2018

Figure Middle East & Africa Sexual Dysfunction Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Table Middle East & Africa Sexual Dysfunction Drugs Market Size (Million USD) by Players (2013-2018)

Figure Middle East & Africa Sexual Dysfunction Drugs Market Size Share by Players in 2017

Figure Middle East & Africa Sexual Dysfunction Drugs Market Size Share by Players in 2018

Figure Global Sexual Dysfunction Drugs Market Size (Million USD) by Regions (2018-2025)

Table Global Sexual Dysfunction Drugs Market Size (Million USD) by Regions (2018-2025)

Figure Global Sexual Dysfunction Drugs Market Size Share by Regions in 2018

Figure Global Sexual Dysfunction Drugs Market Size Share by Regions in 2025

Figure North America Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate (2018-2025)

Figure Europe Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate (2018-2025)

Figure China Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate (2018-2025)

Figure Rest of Asia Pacific Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate (2018-2025)

Figure Central & South America Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate (2018-2025)

Figure Middle East & Africa Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate (2018-2025)

Table Global Sexual Dysfunction Drugs Market Size (Million USD) by Type (2018-2025)

Figure Global Sexual Dysfunction Drugs Market Size Share by Type in 2018

Figure Global Sexual Dysfunction Drugs Market Size Share by Type in 2025

Table Global Sexual Dysfunction Drugs Market Size (Million USD) by Application (2018-2025)

Figure Global Sexual Dysfunction Drugs Market Size (Million USD) by Application in 2018

Figure Global Sexual Dysfunction Drugs Market Size (Million USD) by Application in 2025